Cargando…
Author Correction: AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines
Autores principales: | Zhang, Liyang, Zuris, John A., Viswanathan, Ramya, Edelstein, Jasmine N., Turk, Rolf, Thommandru, Bernice, Rube, H. Tomas, Glenn, Steve E., Collingwood, Michael A., Bode, Nicole M., Beaudoin, Sarah F., Lele, Swarali, Scott, Sean N., Wasko, Kevin M., Sexton, Steven, Borges, Christopher M., Schubert, Mollie S., Kurgan, Gavin L., McNeill, Matthew S., Fernandez, Cecilia A., Myer, Vic E., Morgan, Richard A., Behlke, Mark A., Vakulskas, Christopher A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290028/ https://www.ncbi.nlm.nih.gov/pubmed/34282150 http://dx.doi.org/10.1038/s41467-021-24770-w |
Ejemplares similares
-
AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines
por: Zhang, Liyang, et al.
Publicado: (2021) -
Efficiency, Specificity and Temperature Sensitivity of Cas9 and Cas12a RNPs for DNA-free Genome Editing in Plants
por: Banakar, Raviraj, et al.
Publicado: (2022) -
Systematic in vitro profiling of off-target affinity, cleavage and efficiency for CRISPR enzymes
por: Zhang, Liyang, et al.
Publicado: (2020) -
Optimized design parameters for CRISPR Cas9 and Cas12a homology-directed repair
por: Schubert, Mollie S., et al.
Publicado: (2021) -
Evaluation and Reduction of CRISPR Off-Target Cleavage Events
por: Vakulskas, Christopher A., et al.
Publicado: (2019)